How do patients feel during the first 72 h after initiating long-acting injectable buprenorphine? An embodied qualitative analysis
Tallennettuna:
Neale, J., et al., How do patients feel during the first 72 h after initiating long-acting injectable buprenorphine? An embodied qualitative analysis. Addiction, vol. 118, n. 7, 2023, p. 1329-1339.
Ref.
586599
Sijainti:
SIIS Archivo (R.696)
Palabras clave:
Drogodependencias, Drogas ilegales, Opiáceos, Tratamiento, Innovaciones, Buprenorfina, Vía intravenosa, Actitudes usuarios, Beneficios, Efectos no deseados, Emociones, Bienestar, Salud, Estudio cualitativo, Reino Unido
Drogodependencias, Drogas ilegales, Opiáceos, Tratamiento, Innovaciones, Buprenorfina, Vía intravenosa, Actitudes usuarios, Beneficios, Efectos no deseados, Emociones, Bienestar, Salud, Estudio cualitativo, Reino Unido
Samankaltaisia teoksia: How do patients feel during the first 72 h after initiating long-acting injectable buprenorphine? An embodied qualitative analysis
- BUPRENORPHINE DIVERSION AND INJECTION IN MELBOURNE, AUSTRALIA: AN EMERGING ISSUE?
- Long-acting injectable depot buprenorphine from a harm reduction perspective in patients with ongoing substance use and multiple psychiatric comorbidities: a qualitative interview study
- POOR MAN'S SMACK: A QUALITATIVE STUDY OF BUPRENORPHINE INJECTING IN MELBOURNE, AUSTRALIA
- Criminal charges prior to and after initiation of office-based buprenorphine treatment
- PREDICTING INITIATION TO AND CESSATION OF BUPRENORPHINE AND TEMAZEPAM USE AMONGST ADOLESCENTS
- COMPARING RETENTION IN TREATMENT AND MORTALITY IN PEOPLE AFTER INITIAL ENTRY TO METHADONE AND BUPRENORPHINE TREATMENT